JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 49 filers reported holding JANUX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,498,193 | +5.0% | 942,281 | +23.7% | 0.00% | – |
| Q2 2023 | $9,044,820 | -3.3% | 761,990 | -1.4% | 0.00% | – |
| Q1 2023 | $9,349,125 | -5.9% | 772,655 | +2.4% | 0.00% | – |
| Q4 2022 | $9,938,345 | -3.5% | 754,620 | -0.8% | 0.00% | – |
| Q3 2022 | $10,297,000 | +29.8% | 760,474 | +17.1% | 0.00% | – |
| Q2 2022 | $7,932,000 | -2.3% | 649,640 | +14.8% | 0.00% | – |
| Q1 2022 | $8,116,000 | -22.8% | 565,979 | +6.2% | 0.00% | – |
| Q4 2021 | $10,517,000 | -8.3% | 533,071 | +0.5% | 0.00% | – |
| Q3 2021 | $11,470,000 | +1486.4% | 530,242 | +1729.9% | 0.00% | – |
| Q2 2021 | $723,000 | – | 28,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |